Clinical Trial Update: Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine

View source ↗

Summary

The trial update reports on the association between DPYD gene variants and toxicity from capecitabine in breast cancer patients. Findings may inform pharmacogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Status: COMPLETED